Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Intangibles (2023 - 2025)

bioAffinity Technologies (BIAF) has disclosed Intangibles for 3 consecutive years, with $745972.0 as the latest value for Q2 2025.

  • On a quarterly basis, Intangibles changed N/A to $745972.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $745972.0, a N/A change, with the full-year FY2024 number at $775139.0, down 7.0% from a year prior.
  • Intangibles was $745972.0 for Q2 2025 at bioAffinity Technologies, down from $775139.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $2.2 million in Q1 2024 to a low of $745972.0 in Q2 2025.
  • A 3-year average of $1.1 million and a median of $811597.0 in 2023 define the central range for Intangibles.
  • Biggest YoY gain for Intangibles was 7.0% in 2024; the steepest drop was 31.27% in 2024.
  • bioAffinity Technologies' Intangibles stood at $833472.0 in 2023, then decreased by 7.0% to $775139.0 in 2024, then dropped by 3.76% to $745972.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Intangibles are $745972.0 (Q2 2025), $775139.0 (Q4 2024), and $789722.0 (Q3 2024).